Skip to main content
logo
Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
180.70
-12.40 (-6.42%)
Jul 21, 2026, 4:08 PM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Generic Drugs
582.36M466.68M--
Generic Drugs Growth
24.79%---
Pharmaceuticals
--316.63M212.47M
Pharmaceuticals Growth
--49.03%-
Total
582.36M466.68M316.63M212.47M
Total Growth
24.79%47.39%49.03%-

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Mainland China
582.36M466.68M316.63M212.47M
Mainland China Growth
24.79%47.39%49.03%-
Total
582.36M466.68M316.63M212.47M
Total Growth
24.79%47.39%49.03%-